Rs.1,301
d due to high customer inventory ▪ Cashflow From Operations: Healthy cash flow from operations of Rs.1,301 Mn with a Net Debt to EBITDA ratio of 0.90x. ▪ Product Approvals: Received approvals for Bupropi
0.90x
m Operations: Healthy cash flow from operations of Rs.1,301 Mn with a Net Debt to EBITDA ratio of 0.90x. ▪ Product Approvals: Received approvals for Bupropion SR Tabs and Lisdexamphetamine Chew Tabs
2%
ce Q3 FY25 Q3 FY24 Y-o-Y Gr% Remarks on Y-o-Y performance (In ₹ Mn) Revenue 11,377 11,556 -2% Gross Margin Gross Margin % EBITDA EBITDA % PAT PAT % 7,020 61.7% 2,303 20.2% 1176 10.3
61.7%
) Revenue 11,377 11,556 -2% Gross Margin Gross Margin % EBITDA EBITDA % PAT PAT % 7,020 61.7% 2,303 20.2% 1176 10.3% 6,583 57.0% 2,505 21.7% 1,257 10.9% 7% -8% -6% YoY growth in F
20.2%
,377 11,556 -2% Gross Margin Gross Margin % EBITDA EBITDA % PAT PAT % 7,020 61.7% 2,303 20.2% 1176 10.3% 6,583 57.0% 2,505 21.7% 1,257 10.9% 7% -8% -6% YoY growth in FD has been off
10.3%
-2% Gross Margin Gross Margin % EBITDA EBITDA % PAT PAT % 7,020 61.7% 2,303 20.2% 1176 10.3% 6,583 57.0% 2,505 21.7% 1,257 10.9% 7% -8% -6% YoY growth in FD has been offset by the co
57.0%
rgin Gross Margin % EBITDA EBITDA % PAT PAT % 7,020 61.7% 2,303 20.2% 1176 10.3% 6,583 57.0% 2,505 21.7% 1,257 10.9% 7% -8% -6% YoY growth in FD has been offset by the continued decli
21.7%
rgin % EBITDA EBITDA % PAT PAT % 7,020 61.7% 2,303 20.2% 1176 10.3% 6,583 57.0% 2,505 21.7% 1,257 10.9% 7% -8% -6% YoY growth in FD has been offset by the continued decline in API/PFI
10.9%
EBITDA % PAT PAT % 7,020 61.7% 2,303 20.2% 1176 10.3% 6,583 57.0% 2,505 21.7% 1,257 10.9% 7% -8% -6% YoY growth in FD has been offset by the continued decline in API/PFI due to lower d
7%
A % PAT PAT % 7,020 61.7% 2,303 20.2% 1176 10.3% 6,583 57.0% 2,505 21.7% 1,257 10.9% 7% -8% -6% YoY growth in FD has been offset by the continued decline in API/PFI due to lower deman
8%
PAT PAT % 7,020 61.7% 2,303 20.2% 1176 10.3% 6,583 57.0% 2,505 21.7% 1,257 10.9% 7% -8% -6% YoY growth in FD has been offset by the continued decline in API/PFI due to lower demand and
6%
PAT % 7,020 61.7% 2,303 20.2% 1176 10.3% 6,583 57.0% 2,505 21.7% 1,257 10.9% 7% -8% -6% YoY growth in FD has been offset by the continued decline in API/PFI due to lower demand and pers